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Dietary fibre alone does not fully explain the frequent association between greater intake of
whole grains and reduced risk of disease in observational studies, and other phytochemicals
or food structure may also play an important role. For all the observational evidence for the
benefits of a whole-grain-rich diet, we have only limited knowledge of the mechanisms be-
hind this reduction in disease risk, aside from the action of specific cereal fibres on reduction
of blood cholesterol and the post-prandial glucose peak. Nutritional metabolomics, the glo-
bal measurement and interpretation of metabolic profiles, assesses the interaction of food
with the endogenous gene–protein cascade and the gut microbiome. This approach allows
the generation of new hypotheses which account for systemic effects, rather than just focus-
ing on one or two mechanisms or metabolic pathways. To date, animal and human trials
using metabolomics to investigate mechanistic changes to metabolism on eating whole
grains and cereal fractions have led to new hypotheses around mechanistic effects of
whole grains. These include the role of cereals as a major source of dietary glycine betaine,
a possible effect on phospholipid synthesis or metabolism, the role of branched-chain amino
acids and improvements in insulin sensitivity, and the possibility that whole grains may have
an effect on protein metabolism. These hypotheses help explain some of the observed effects
of whole grains, although mechanistic studies using stable isotopes and fully quantitative
measures are required to confirm these potential mechanisms.
Whole grains: Metabolomics: Insulin sensitivity: Protein turnover: Betaine: Health benefits
Whole grains are associated with health, but are the
effects only due to fibre?
The association between greater intake of whole grains
and reduced risk of disease is one of the most consistent
findings in nutritional epidemiology(1). The diseases
where whole grains are associated with reduced risk are
diverse, including CVD, diabetes and some types of can-
cer(2). These associations point to potentially diverse
metabolic and physiological effects of whole grains
which might not be fully explain by their macro- and
micronutrient composition alone. Much focus on
explaining the mechanisms behind the lower risk of dis-
ease in people who eat the most whole grain has focused
on dietary fibre(3,4). The greater fibre content of whole
grains is likely an important factor, but may not explain
all observed reduction in disease risk(1). For example,
there are well-established mechanisms for cholesterol
lowering by cereal-derived β-glucan(5), yet the whole
grains that are most commonly consumed in population
studies that find associations between whole grains and
health are wheat, maize and rice, grains that have a
very low content of β-glucan and other soluble fibres.
Other grain components are also likely to play a role in
explaining the mechanism behind whole grains and
health(6). This review explores the role of metabolomics
in finding new hypotheses that fill the gaps on why eating
more whole grains reduces the risk of some diseases.
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Proposed mechanisms behind whole-grain health effects
Prior to the application of metabolomics to research on
whole grains and health, explanations for why observa-
tional studies consistently found associations between
eating more whole grains and reduced risk of many dis-
eases centred on the higher fibre, vitamin and mineral
content, as well as phenolic phytochemicals for their anti-
oxidant capacity(7). Fibre in particularwas thought to be im-
portant not only for reducing blood lipids, but for
promoting the growth of beneficial bacteria and increas-
ing the production of SCFA in the large intestine(7).
Although there is little that is controversial about these
proposed mechanisms, there was little explanation or evi-
dence about how the compositional differences would im-
pact on health. One major change in thinking between the
early 2000s and the present day is the role of phenolic
compounds in cereals as antioxidants, which would in
turn reduce long-term disease incidence by prevention of
oxidative damage. While an attractive explanation at the
time, the theory that phenolic compounds reduce disease
by acting as free-radical scavenging antioxidants has not
been borne out in clinical intervention trials that have con-
sistently found that high intake of antioxidant compounds
has little effect on in vivo antioxidant capacity, and no
effect on health outcomes(8).
Prior to the advent of systems biology tools, most stu-
dies looking to understand the effect of whole grains on
health have focused on a few clinically relevant endpoints
including blood lipids, glucose and markers of inflamma-
tion. This has given some insight into possible mechan-
isms, but may not have been informative about the
global impact of whole grains. For the past decade
researchers have been encouraging the greater use of
newer methodologies, including metabolomics, in nu-
trition in the search for a better understanding of the
link between whole grains and health.
Metabolomics: an ideal tool to study biological
mechanisms
Metabolomics is the field of analytical chemistry focused
on measuring a broad spectrum of metabolites, normally
to understand the global, or systemic, effects of a biologi-
cal change, such as disease, environment or diet.
Metabolites are the end product of the cascade from
genes to proteins and then to metabolites, and as such
reflect gene and protein modifications such as epigenetic
modifications, and protein phosphorylation and glycosy-
lation. In addition to endogenous metabolites, mam-
malian plasma and urine also contain metabolites that
originate from gut microbial metabolism, and can be a
window into the status of the gut microbiota.
A number of different methods are used to collect
metabolomics data, the most common being proton
NMR spectroscopy and GC or liquid chromatography
coupled to MS (GC–MS or LC–MS). Several papers
have addressed the key advantages of the various techni-
ques(9). For the purposes of this review, it should be
noted that proton NMR requires less sample preparation
and generally has less instrumental drift (instrument re-
sponse will be very similar for the first or the 100th sam-
ple), whereas MS-based techniques are more sensitive
and can detect more metabolites, but have higher run
to run variation that needs to be corrected for statisti-
cally. High resolution MS can detect thousands of meta-
bolites and in recent years have shown promise to greatly
enhance our understanding of the breadth of metabolites
present in human and food samples. After chemical
analysis, the critical steps of post-run data analysis,
where the acquired data are aligned and normalised,
and statistical analysis are used to determine which of
the dozens to thousands of measured metabolic features
are predictive of the study question.
Although metabolomics holds much promise for ad-
vancing biological understanding, it needs to be empha-
sised that the goal of metabolomics is to generate
hypotheses around metabolic mechanisms, rather than
to definitively prove a mechanism or an effect. Because
of the statistical and analytical problems in analysing
large numbers of metabolites, hypotheses generated
based on a metabolomics study need to be followed up
with studies specifically powered to test that hypothesis,
with analysis carried out using validated quantitative
methods.
Metabolomic insights into whole-grain health benefits:
animal studies
The first studies on the global impact of a whole-grain
diet have been based on samples from animal studies.
The first such paper highlighted the potential importance
of the methyl donor glycine betaine (betaine) from a
whole-grain rye and rye bran enriched bread fed to pigs
as a potential mediator of health effects of whole grains
and bran-rich cereals(10). Urinary urea and creatinine
were reduced when pigs were fed rye bread, while urinary
hippurate was elevated. Later, a decrease in urinary urea
and creatinine due to a whole-grain diet were linked to
protein turnover in human subjects(11), while urinary hip-
purate is often described as a product of microbial
metabolism of phenolic compounds, although it may
also come from metabolism of aromatic amino
acids(12). This work underlined the potential role of
whole grains in interacting with gut microbiota, and for
the first time linked the high concentration of betaine
in rye to improved betaine status in a mammalian model.
Analysis of liver tissue samples from hypercholestero-
laemic pigs fed either a high-fibre rye bread diet, or a
high-fibre refined wheat diet using magic angle spinning
proton NMR indicated differences to liver lipid metab-
olism, with high-fibre rye leading to an increase in liver
free-choline, while the refined wheat diet led to elevated
glycerophosphocholine and phosphocholine, suggesting
a change in the expression or activity of phospholi-
pases(13). Notably there was no difference in the signal
from trimethylamine oxide/betaine (the NMR signal
for both overlaps making differentiation difficult),
although plasma betaine was found to be increased
in the same pigs(14). Lipids, possibly TAG, were decreased
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in plasma (14), suggesting a possible link between changes
to liver phospholipids and lipid transport and circulation
in blood. A secondary study on the same hypercholester-
olaemic pig model using untargeted LC–quadrupole
time-of-flight MS metabolomics also found evidence for
remodelling of lipid metabolism, with reduced plasma
concentrations of linoleic acid-derived oxylipins and chol-
esterol on the rye bread-based diet(15). In the present
study, the mammalian lignan enterolactone was detected
and highly elevated on the rye diet, a finding backed up
by previous studies on similar pig models(16). In a study
designed to compare metabolic responses between pigs
and human subjects, both species were fed either whole-
grain rye or refined wheat, and post-prandial plasma
metabolic profile responses were compared(17). Pigs and
human subjects had similar relative metabolic changes
for twenty-one out of twenty-six metabolites that were
predictive of the different diet interventions in both spe-
cies, indicating that pig models give a good reflection of
human metabolism of cereals. Among the compounds
that were different between the refined and whole-grain
rye diets for both pigs and human subjects in this study
were phosphatidylcholines 38 : 4 and 36 : 4, and lysopho-
sphocholine 18 : 1, which were all elevated on the rye ker-
nel diet compared with the refined wheat bread diet(17).
These initial studies had focused on a high-fibre rye
bread diet, based on whole-grain rye and rye bran, com-
pared with a fibre (wheat cellulose) matched refined
wheat diet. A rat study comparing a whole-grain wheat
diet v. a non-fibre matched refined wheat diet identified
several changes in urine, plasma and liver-extract related
to the whole-grain wheat diet(18). Contrary to the results
for pigs, urinary creatine was elevated on the whole-grain
wheat diet, along with urinary amino acids (tyrosine, tryp-
tophan and phenylalanine) and hippurate. Excretion
of central carbon metabolism metabolites citrate and
fumarate were increased, while pyruvate excretion was
decreased, hinting at a possible change to energy metab-
olism. A signal attributed to either trimethylamine oxide
or taurine was also decreased on the whole-grain wheat
diet. Plasma lipids and lysine were slightly elevated
(∼ 10 % increase) on the whole-grain wheat diet. Feeding
whole-grain wheat also led to a decrease in liver lipids,
and an increase in glucose, glutathione and the trimethyla-
mine oxide/betaine signal. The present study also found
many NMR signals that were significantly different
between diets, but could not be identified(18).
The role of gut microbiota in the release and avail-
ability of phytochemcials from cereal fibre was well dem-
onstrated in a metabolomics study on mouse urine after
feeding with differently processed wheat aleurone layer
fractions. A large number of metabolites, including hip-
purate, dihydrophenolic acids and benzoxazinoids meta-
bolites were released from the fibre matrix when the
aleurone layer was milled or ultramilled. Fermentation
of the aleurone layer feed led to a different urinary metab-
olite response altogether, including many unknown meta-
bolites and small phenolic acids(19). Although this work
did not link the different responses to metabolic endpoints
in the mice, it is a clear demonstration of the ability of
metabolomics to detect differences in gut microbiota-
related metabolites, as well as to discriminate between
fermented and non-fermented diets.
Together, these first animal studies highlighted the link
between the high concentration of betaine in wheat and
rye to increases in circulating and tissue betaine, as well
as the likely increased metabolism of phenolics by the
gut microbiota as indicated by hippurate, enterolactone
and a diverse range of other phenolic metabolites
released from the fibre matrix. Possible effects on lipid
metabolism were also detected in porcine liver and
plasma, and as some of these involved phospholipids
with choline moieties, these changes may be related
to improved betaine status via choline sparing.
Unfortunately none of these studies were able to link
metabolic changes to health-related outcomes, although
do give a picture of the potential scope for the metabolic
effects of whole grains.
Metabolomic insights into whole-grain health benefits:
human studies
Detecting metabolic changes due to diet in human sub-
jects is more complicated than in animal models due to
the wide genetic variation in the population (animals
are often siblings) and variation in food intake aside
from the intervention. Whole grain brings the additional
problem that it inherently cannot be condensed into a pill
or extract, so proportionally it cannot make up as large a
part of the diet as rats or pigs being fed a fortified bread
diet. Nevertheless, several studies have found that whole-
grain diets do induce some metabolic differences com-
pared with refined grain-based diets.
In a cohort of hypercholesterolaemic post-menopausal
women partaking in a crossover study feeding either
high-fibre refined wheat bread or high-fibre rye bread,
several new metabolites were identified as related to the
high-fibre rye diet: concentrations of the ribose metabo-
lites ribitol and ribonic acid were elevated, as was the
tryptophan metabolite indole acetic acid(20). The authors
correlated ribonic acid with tryptophan, and speculated
that this may be because of an increased synthesis of ser-
totonin, and reduced hunger. Hunger was not measured
in the present study, and serotonin was not directly mea-
sured, making this link somewhat speculative, although
several studies have found that rye is more satiating
than other cereals(21,22). Serum cholesterol increased on
the high-fibre rye bread diet, although the fatty acids pal-
mitic acid, oleic acid and myristoleic acid were decreased
in plasma during the rye bread period(20) supporting the
hypothesis of an effect on fatty acid metabolism beyond
cholesterol.
Elevated plasma betaine has also been found in meta-
bolomics studies in human subjects. In an intervention
with a high intake of whole-grain rye bread with added
rye bran, carried out in males diagnosed with the early
stage prostate cancer, elevated plasma betaine and
dimethylglycine, the post-methyl donation metabolite of
betaine, were measured, backed up by a trend for reduced
homocysteine during the intake of rye bread(23). Elevated
plasma 3-hydroxybutyric acid and acetone was suggested
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to be related to a shift in energy metabolism from ana-
bolic to catabolic state while fasting. This same study
found that the rye bread diet improved glucose metab-
olism (reduced urinary C-peptide and plasma insulin)
and reduced plasma prostate-specific antigen, a marker
of prostate cancer risk(24). Other studies specifically ana-
lysing betaine found that whole-grain-rich or cereal
betaine-enriched diets led to an increased amount of cir-
culating betaine(25,26), and that with very high doses of
cereal betaine from the wheat aleurone layer, downstream
effects on reducing homocysteine and increasing
dimethylglycine and methionine could be measured(25).
In work carried out on post-menopausal women, a
group of the population at risk of developing type 2 dia-
betes, both fasting and post-prandial plasma samples had
lower leucine and isoleucine concentrations when fed a
whole-grain rye bread compared with refined grain
bread(27,28). These results are the first indication that
whole grains may have an impact on branched-chain
amino acid (BCAA) metabolism, which may in part
explain the mechanism how whole grains reduce insulin
resistance (see further discussion later).
Although not a whole-grain study per se, Bondia-Pons
et al.(29) studied the possible metabolic mechanism be-
hind why sourdough endosperm rye bread gives a
lower post-prandial insulin compared with refined
wheat bread, using two-dimensional GC–MS based
metabolomics. Similar to studies where whole-grain
rye/rye bran has been the major intervention, amino
acids increased (methionine and phenylalanine), as well
as ribitol, a breakdown product of tryptophan, increased
after the rye endosperm bread. Organic acids (butene-
dioic acid, ascorbic acid, picolinic acid and succinic
acid) were increased after the refined wheat bread meal.
The authors noted that both ribitol and picolinic acid
are breakdown products of tryptophan, but with differ-
ent responses to either rye endosperm bread or refined
wheat bread. Their possible biological effects are also
quite different, with picolinic acid suggested to induce
inflammatory proteins in macrophages(29). The similar
finding of a possible effect on tryptophan metabolism
as earlier described(20) gives greater weight to the hypo-
thesis that eating cereal-based foods has an effect on aro-
matic amino acid metabolism.
A study comparing a refined-cereal based diet with
either a whole-grain-based diet or a ‘healthy diet’ with
whole grains, fish and Nordic berries found that the
healthy diet intervention led to both changes to glucose
response (2 h glucose and glucose area under the curve),
and several changes to the lipidomic response, including
n-3 fatty acids that would be expected to increase with
increased fish intake, and many changes to TAG, phos-
phatidylcholine species and phosphatidylethanolamine
species, indicating a wide ranging remodelling of circulat-
ing lipids due to the healthy diet(30). Conversely, the
whole-grain-based diet, which included both wheat-
and rye-based products, did not lead to any changes to
the lipidome relative to the control diet(30). Although it
is difficult to decipher differences in mixed diet interven-
tions, it would appear that in this free-living study design,
whole grains were not the main driver of changes in lipids
in the healthy diet intervention. No health-related end-
points changed with the whole-grain diet (although a
trend for decreased 2 h glucose was observed), which
may fit with the observation that there was no major
metabolic response to the intervention diet. These data
support the idea that analysing the metabolome in sam-
ples from interventions where no primary outcomes
change may be pointless, as any measured change in pri-
mary outcome should be reflected in a change in meta-
bolic homeostasis. Null results are not published as
frequently as ‘difference’ results, and it can be interpreted
from the results found here that unless the primary goal
is to find diet-specific biomarkers, metabolomics analysis
of samples where no primary or secondary outcomes
have changed will be unlikely to find any further changes
to the metabolome. An additional observation is that
multivariate models generated from metabolomics analy-
ses whole-grain-based clinical trials is that they are often
weak. This indicates a wide inter-individual variation in
overall metabolic response, and that other factors such
as other types of food intake are stronger drivers of meta-
bolic differences than the whole-grain intervention itself.
Care needs to be taken to ensure validation of multivari-
ate models and to confirm results using correction for
multiple testing.
Unifying or common mechanisms for whole grains and
health benefits
Betaine and phospholipids
Although there are many disparate findings between the
different studies reported here, there are some common
themes for changes to metabolic pathways. The increase
in plasma betaine was the first major metabolite change
due to a whole-grain cereal diet that was highlighted
using metabolomics, and this may explain some of the
other metabolic observations related to changes to
phospholipid metabolism and even insulin resistance.
Betaine, as a methyl donor, remethylates homocysteine
to methionine, a change that has been demonstrated in
human subjects using betaine-rich wheat aleurone por-
ridge(25). In the presence of adequate supplies of betaine,
less choline is used for the remethylation of homocys-
teine, allowing choline to be used for the production
of phospholipids that make up a large proportion of
cell membranes(31). Postprandial plasma phospholipid
concentrations of two phosphatidylcholines increased
in both pigs in human subjects (17), and although beta-
ine was not measured, a post-prandial rise in betaine
following eating whole grains has been measured
in human subjects(26). Whole-grain intake was asso-
ciated with lower fasting plasma phosphatidylcholine
concentrations in the European Prospective Investigation
into Cancer and Nutrition cohort(32), although post-
prandial and fasting samples reflect very different meta-
bolic states. Changes to the enzyme activities related to
phospholipid biosynthesis may also explain these differ-
ences, although interaction between cereal components
and lipid biosynthesis enzymes are yet to be tested.
The composition of phosphatidylcholine in
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biomembranes may be important for health, as this can
impact on membrane fluidity, which consequently can
alter cell integrity and the activity of membrane-based
enzymes, with possible long-term consequences for cellu-
lar function and repair(33).
Recent work using a mouse model of diet-induced
obesity found that mice supplemented with betaine not
only increased plasma, muscle and liver betaine, but
also led to an increase in carnitine and short-chain acet-
ylcarnitines in liver and muscle(34). These increases were
not associated with any phenotypic changes, but do pro-
vide evidence for an interaction between betaine and
lipid metabolism, and potentially a further link to
glucose metabolism (see later).
Betaine may be of additional interest as a universal
mediator of whole-grain health benefits, as a methyl
donor for epigenetic modifications. Although whole
grains have yet to be tested directly for epigenetic effects,
betaine supplementation in rodents is able to change
DNA methylation patterns with possible effects on meta-
bolic enzymes(35,36), and given that whole-grain wheat,
rye and quinoa are among the best dietary sources of
betaine(37), they will be important epigenetic mediators
if betaine’s role in DNA methylation is confirmed in
human subjects.
Branched-chain amino acids, aromatic amino acids,
acyl-carnitines and glycaemic control
The findings by Moazzami et al. that rye-based diets de-
crease circulating BCAA(23,27,28) may explain the reduced
risk of diabetes seen in observational studies. However,
many of the observational studies have been carried
out in populations with low intake of rye, suggesting
that an effect on glycaemic control may not be unique
for rye-based foods. Two recent studies have found that
a diet based mainly on whole-grain wheat led to
improved measures of glucose control(38,39), although
no analyses of BCAA has been reported in these studies.
Newgard reported that elevated BCAA were clustered
with C3 and C5, acylcarnitines, as well as aromatic
amino acids phenylalanine, tryptophan and tyrosine(40).
This formed the basis for a hypothesis of an interaction
between elevated BCAA and muscle mitochondrial util-
isation of energy(40). There may be some evidence for
whole grains interacting with carnitine metabolism,
with carnitine and acetylcarnintine excretion being
reduced on a mixed whole-grain diet(41) although exact
assignment of chain length of a carnitine by NMR can
be difficult. Supporting the hypothesis that a whole-grain
diet leads to lower concentrations of BCAA, a metabolo-
mic analysis of the European Prospective Investigation
into Cancer and Nutrition-Potsdam cohort, whole-grain
intake was associated with lower plasma valine and iso-
leucine concentrations, along with the aromatic amino
acid tyrosine(32). This same metabolite pattern was also
associated with reduced risk of type 2 diabetes, adding
weight to the idea that whole grains may play a role in
amino acid metabolism.
The changes to BCAA and insulin resistance may also
help explain the finding that protein catabolism appears
to be reduced on a whole-grain diet compared with a
refined grain diet(41), and may also lend some support
to the possibility that whole grains can improve body
composition(42–44), given that increased insulin sensitivity
improves muscle mass, probably via insulin-mediated
phosphorylation of the enzymes used for muscle syn-
thesis(45). Although there is good observational evidence
for whole grains reducing the risk of type 2 diabetes,
there is only limited information on the effect of whole
grains on glucose metabolism kinetics and insulin re-
sponse. In a single meal study, whole-grain barley
improved peripheral insulin sensitivity as indicated by
an increased rate of glucose disappearance(46). Recent
work supports the present hypothesis that whole grains
reduce peripheral insulin resistance compared with
refined grains(39), even though no effects on body compo-
sition were found in the 8-week study. Further work is
required to determine if these well-characterised changes
in glucose metabolism also match the metabolite changes
found in metabolomics studies. At present it appears as
though whole grains may improve peripheral insulin up-
take, but a direct impact on or role for skeletal muscle
would still need to be established.
All these studies taken together would form a basis for
supporting that a whole-grain-rich diet improves insulin
sensitivity by suppressing the suggested BCAA-driven
pathway for increased insulin resistance. Findings that
tyrosine and tryptophan metabolism may also be altered
by whole-grain interventions(20) adds further interest as
these along with the BCAA are often associated with in-
sulin resistance(47–49).
The relatively low number of studies carried out on
highly disparate study designs is a weakness in trying
to establish common mechanisms for disease reduction.
Studies where detailed clinical analyses and comprehen-
sive metabolomics analyses are performed and data
analyses focus on linking the two will allow better under-
standing of the link between metabolism and clinical
outcomes.
A role for gut microbiota
Although the commonly found microbial metabolite hip-
purate was found in several studies, there were few other
clear indications of the effect of gut microbiota on the
metabolome. One study, which also measured changes
in gut microbiota composition, also found a decrease in
the microbial metabolites of choline, dimethylamine
and trimethylamine present in urine when eating whole
grains(41). This link is of current interest given the poten-
tial role of gut microbial metabolism of choline in the
evolution of CVD risk(50). The same study also measured
increased faecal output of acetate and butyrate using
metabolomics, the concentrations of which were asso-
ciated with decreased faecal water pH. The increased
production of SCFA by gut microbiota is often stated
as being one of the mechanisms for how whole grains
may reduce insulin resistance, cholesterol synthesis and
increase satiety; however changes to plasma SCFA are
rarely found after whole-grain interventions. Effects on
microbial metabolism of choline have not been reported
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in other studies, and it will be of interest if this were
confirmed in future work.
Other indications of interactions with gut microbiota
are the diversity of phenolic compounds found in plasma
and urine after the intake of phenolic rich wheat aleurone-
based diets in mice(19). Although linking the relatively low
concentrations of these compounds to reduced risk of dis-
ease will prove challenging, it does provide evidence that
gut microbiota are metabolising the diverse array of phe-
nolic compounds present in whole grains, and it can be
speculated that this may drive greater microbial
diversity to adapt to the more diverse substrate, a factor
implicated in the prevention of obesity(51).
Identification of novel metabolites related to whole-grain
cereal exposure
Identifying cereal-related compounds linked to whole-
grain intake can be a valuable tool in the search for
novel biomarkers of food intake. Biomarkers of food in-
take can help improve estimates of food intake from
questionnaires in observational studies, and be used to
check compliance in dietary intervention studies. Using
metabolomics, Beckmann et al. identified novel benzox-
azinoid metabolites, 2-hydroxy-N-(2-hydroxyphenyl)
acetamide and N-(2-hydrxyphenyl) acetamide, in urine
as being specific biomarkers of sourdough rye intake(52).
The benzoxazinoid metabolite 2,4-dihydroxy-1,4-ben-
zoxazin-3-one sulphate was also linked to intake of rye
bread based on metabolomic analysis of urine samples(53),
whereas 2-hydroxy-N-(2-hydroxyphenyl) acetamide sul-
phate and N-(2-hydrxyphenyl) acetamide sulphate were
identified in post-prandial plasma samples, discriminating
between rye sourdough and rye bran bread, and refined
wheat bread(54). While previously known as plant allelo-
chemicals, benzoxazinoids were rarely mentioned among
the potentially beneficial compounds present in cereal grains.
Metabolomics has helped to rekindle interest in benzoxazi-
noids and how they may play a role in the health benefits
of rye in particular(6). Metabolomics has also confirmed
that cereal alkylresorcinols are usefulmarkers ofwhole-grain
intake, with two studies confirming that alkylresorcinol
metabolites in urine are related to both whole-grain wheat
and rye intake(53,55).
Research on whole grains tends to focus on health ben-
efits, although eating the outer layers of the grain can
also lead to greater exposure to toxic contaminants that
may be present in the outer layers. The toxic fungal
metabolite deoxynivalenol, when present, is found at
highest concentrations in the bran fraction of the grain,
and has been suggested to be potentially deleterious for
human health(56). A small scale metabolomics study com-
paring urine from people with high v. low deoxynivalenol
exposure found that urinary hippurate was the most dis-
criminating metabolite, with highest concentrations
being present in people with greatest deoxynivalenol ex-
posure(56). Hippurate is frequently associated with a
greater exposure to plant-based foods, and this case is
more likely to be a marker of greater intake of cereal
foods, which also increases the chance for deoxynivalenol
exposure, rather than a direct metabolite from microbial
metabolism of the fungal toxin.
What does the future hold?
Metabolomics is proving to be a useful tool for identify-
ing novel pathways that are impacted by whole-grain
diets, although as for the results on disease markers
and other clinical chemistry endpoints, the results are
mixed. However, there are some fairly consistent changes
observed in several of the studies, including changes that
can be related to energy metabolism, lipid metabolism
and one-carbon metabolism. For these observations to
be credible it is necessary to move beyond ‘changes’
and to start quantifying metabolites from the relevant
pathways to confirm their role in the observed outcomes.
This would require greater advances in the use of semi-
and fully-quantitative metabolomics as standard, which
would facilitate easier comparison between different
datasets. At present few methods are quantitative due
to the difficulty in applying standard curves that cover
many hundreds of metabolites, even though NMR is
inherently a quantitative method, and MS can be, pro-
vided a suitable spectrum of internal standards are used.
Notwithstanding future improvements in metabolomics
methodology, at the heart of conclusive research on the
mechanisms behind whole-grain health benefits lies
greater consistency in how pre-clinical and clinical trials
are carried out, including what type of grains and grain
products are used. With the enormous heterogeneity of
populations studied, intervention duration on top of the
different products used, we should expect heterogeneous
results. Another key gap is knowledge about metabolic re-
sponse to grains aside from wheat and rye. At present
there is a lack of understanding on how commonly con-
sumed grains such as rice and maize may be beneficial
for health, and lack of biomarkers for their intake. If it
is possible to determine if there is commonality in meta-
bolic responses between different grains then it will aid
in understanding if it is necessary to discuss whole grains
and health, or study the effect of individual grains.
Future work also needs to include a greater emphasis
on molecular mechanisms. Unfortunately intact whole
grains are not so amenable to in vitro studies commonly
used to test mechanisms, so work may be limited to pure
compounds or digests to try and best mimic what is ab-
sorbed from whole grains.
The application of metabolomics to studies where the
effects of whole-grain or related interventions have been
studied has broadened our view of how whole grains may
mediate health benefits. Instead of just focusing on estab-
lished clinical markers often associated with fibre, a re-
searcher in the field can now consider a deeper role for
impacts on lipid, glucose and protein metabolism, as
well as the emerging field of epigenetics. Greater work
is needed to establish if there is any causality between
the phytochemicals found in grains and these metabolic
effects, but we can now start adding more detail to the
previously hypothesised mechanisms behind whole-grain
health benefits.
Whole grains, metabolomics and health 325
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0029665114001542






















The author acknowledges the support of a Chalmers





The author has been a consultant for Nestec SA, the
research arm of the Nestlé food and beverage company,
and Cereal Partners Worldwide. This work is completely
independent of any consulting work carried out.
Authorship
The author was solely responsible for all aspects of prep-
aration of this paper.
References
1. Ye EQ, Chacko SA, Chou EL et al. (2012) Greater
whole-grain intake is associated with lower risk of type 2
diabetes, cardiovascular disease, and weight gain. J Nutr
142, 1304–1313.
2. Frølich W, Åman P & Tetens I (2013) Whole grain foods
and health – A Scandinavian perspective. Food Nutr Res
57; Epublication 12 February 2012. Available at http://
www.ncbi.nlm.nih.gov/pubmed/23411562.
3. Satija A & Hu FB (2012) Cardiovascular benefits of dietary
fiber. Curr Atheroscl Rep 14, 505–514.
4. Smith CE & Tucker KL (2011) Health benefits of cereal
fibre: a review of clinical trials. Nutr Res Rev 24, 118–131.
5. Lattimer JM & Haub MD (2010) Effects of dietary fiber
and its components on metabolic health. Nutrients 2,
1266–1289.
6. Andersson AAM, Dimberg L, Åman P et al. (2014) Recent
findings on certain bioactive components in whole grain
wheat and rye. J Cereal Sci 59, 294–311.
7. Slavin J (2003) Why whole grains are protective: biological
mechanisms. Proc Nutr Soc 62, 129–134.
8. Myung SK, Ju W, Cho B et al. (2013) Efficacy of vitamin
and antioxidant supplements in prevention of cardio-
vascular disease: systematic review and meta-analysis of
randomised controlled trials. BMJ 346. Available at
http://www.ncbi.nlm.nih.gov/pubmed/23335472.
9. Zulyniak MA & Mutch DM (2011) Harnessing metabolo-
mics for nutrition research. Curr Pharm Biotechnol 12,
1005–1015.
10. Bertram HC, Bach Knudsen KE, Serena A et al. (2006)
NMR-based metabonomic studies reveal changes in the
biochemical profile of plasma and urine from pigs fed
high-fibre rye bread. Br J Nutr 95, 955–962.
11. Ross AB, Pere-Trepat E, Montoliu I et al. (2013) A
whole-grain-rich diet reduces urinary excretion of markers
of protein catabolism and gut microbiota metabolism in
healthy men after one week. J Nutr 143, 766–773.
12. Lees HJ, Swann JR, Wilson ID et al. (2013) Hippurate: the
natural history of a mammalian-microbial cometabolite.
J Proteome Res 12, 1527–1546.
13. Bertram HC, Duarte IF, Gil AM et al. (2007) Metabolic
profiling of liver from hypercholesterolemic pigs fed rye
or wheat fiber and from normal pigs. High-resolution
magic angle spinning 1H NMR spectroscopic study. Anal
Chem 79, 168–175.
14. Bertram HC, Malmendal A, Nielsen NC et al. (2009)
NMR-based metabonomics reveals that plasma betaine
increases upon intake of high-fiber rye buns in hypercholes-
terolemic pigs. Mol Nutr Food Res 53, 1055–1062.
15. Norskov NP, Hedemann MS, Laerke HN et al. (2013)
Multicompartmental Nontargeted LC-MS Metabolomics:
explorative study on the metabolic responses of rye fiber
versus refined wheat fiber intake in plasma and urine of
hypercholesterolemic pigs. J Proteome Res 12, 2818–2832.
16. Laerke HN, Mortensen MA, Hedemann MS et al. (2009)
Quantitative aspects of the metabolism of lignans in pigs
fed fibre-enriched rye and wheat bread. Br J Nutr 102,
985–994.
17. Nielsen KL, Hartvigsen ML, Hedemann MS et al. (2014)
Similar metabolic responses in pigs and humans to breads
with different contents and compositions of dietary fibers:
a metabolomics study. Am J Clin Nutr 99, 941–949.
18. Fardet A, Canlet C, Gottardi G et al. (2007) Whole-grain
and refined wheat flours show distinct metabolic profiles
in rats as assessed by a 1H NMR-based metabonomic
approach. J Nutr 137, 923–929.
19. Pekkinen J, Rosa NN, Savolainen OI et al. (2014)
Disintegration of wheat aleurone structure has an impact
on the bioavailability of phenolic compounds and other phy-
tochemicals as evidenced by altered urinary metabolite
profile of diet-induced obese mice.NutrMetab (Lond) 11, 1.
20. Lankinen M, Schwab U, Seppänen-Laakso T et al. (2011)
Metabolomic analysis of plasma metabolites that may
mediate effects of rye bread on satiety and weight mainten-
ance in postmenopausal women1,2. J Nutr 141, 31–36.
21. Forsberg T, Åman P & Landberg R (2014) Effects of whole
grain rye crisp bread for breakfast on appetite and energy
intake in a subsequent meal: two randomised controlled
trails with different amounts of test foods and breakfast
energy content. Nutr J 13. Avalable at http://www.ncbi.
nlm.nih.gov/pubmed/24661836.
22. Isaksson H, Tillander I, Andersson R et al. (2012) Whole
grain rye breakfast – Sustained satiety during three weeks
of regular consumption. Physiol Behav 105, 877–884.
23. Moazzami AA, Zhang JX, Kamal-Eldin A et al. (2011)
Nuclear magnetic resonance-based metabolomics enable
detection of the effects of a whole grain rye and rye bran
diet on the metabolic profile of plasma in prostate cancer
patients. J Nutr 141, 2126–2132.
24. Landberg R, Andersson SO, Zhang JX et al. (2010) Rye
whole grain and bran intake compared with refined wheat
decreases urinary C-peptide, plasma insulin, and prostate
specific antigen in men with prostate cancer. J Nutr 140,
2180–2186.
25. Price RK, Keaveney EM, Hamill LL et al. (2010)
Consumption of wheat aleurone-rich foods increases fast-
ing plasma betaine and modestly decreases fasting homo-
cysteine and LDL-cholesterol in adults. J Nutr 140,
2153–2157.
26. Ross AB, Bruce SJ, Blondel-Lubrano A et al. (2011) A
whole-grain cereal-rich diet increases plasma betaine, and
tends to decrease total and LDL-cholesterol compared

























27. Moazzami AA, Bondia-Pons I, Hanhineva K et al. (2012)
Metabolomics reveals the metabolic shifts following an in-
tervention with rye bread in postmenopausal women – a
randomized control trial. Nutr J 11, 88.
28. Moazzami AA, Shrestha A, Morrison DA et al. (2014)
Metabolomics reveals differences in postprandial responses
to breads and fasting metabolic characteristics associated
with postprandial insulin demand in postmenopausal
women. J Nutr 144, 807–814.
29. Bondia-Pons I, Nordlund E, Mattila I et al. (2011)
Postprandial differences in the plasma metabolome of
healthy Finnish subjects after intake of a sourdough fer-
mented endosperm rye bread versus white wheat bread.
Nutr J 10, 116.
30. Lankinen M, Schwab U, Kolehmainen M et al. (2011)
Whole grain products, fish and bilberries alter glucose
and lipid metabolism in a randomized, controlled trial:
the sysdimet study. PLoS ONE 6.
31. Zeisel SH (2006) Betaine supplementation and blood lipids:
fact or artifact? Nutr Rev 64, 77–79.
32. Floegel A, von Ruesten A, Drogan D et al. (2013)
Variation of serum metabolites related to habitual diet: a
targeted metabolomic approach in EPIC-Potsdam. Eur J
Clin Nutr 67, 1100–1108.
33. Parks JS, Huggins KW, Gebre AK et al. (2000)
Phosphatidylcholine fluidity and structure affect lecithin:
cholesterol acyltransferase activity. J Lipid Res 41, 546–553.
34. Pekkinen J, Olli K, Huotari A et al. (2013) Betaine sup-
plementation causes increase in carnitine metabolites in
the muscle and liver of mice fed a high-fat diet as studied
by nontargeted LC-MS metabolomics approach. Mol
Nutr Food Res 57, 1959–1968.
35. Medici V, Schroeder DI, Woods R et al. (2014)
Methylation and gene expression responses to ethanol feed-
ing and betaine supplementation in the cystathionine beta
synthase-deficient mouse. Alc Clin Exp Res 38, 1540–1549.
36. Cordero P, Campion J, Milagro FI et al. (2013)
Transcriptomic and epigenetic changes in early liver steato-
sis associated to obesity: effect of dietary methyl donor sup-
plementation. Mol Genet Metab 110, 388–395.
37. Ross AB, Zangger A, Guiraud SP (2014) Cereal foods are
the major source of betaine in the Western diet - Analysis
of betaine and free choline in cereal foods and updated
assessments of betaine intake. Food Chem 145, 859–865.
38. Harris Jackson K, West SG, Vanden Heuvel JP et al.
(2014) Effects of whole and refined grains in a weight-loss
diet on markers of metabolic syndrome in individuals
with increased waist circumference: a randomized
controlled-feeding trial. Am J Clin Nutr 100, 577–586.
39. Malin SK, Kullman EL, Scelsi AR et al. (2014) Whole
Grain Diet Improves Glucose Tolerance, Insulin Sensitivity,
and Beta-Cell Function in Overweight Prediabetic Adults.
American Diabetes Association. San Francisco.
40. Newgard CB (2012) Interplay between lipids and branched-
chain amino acids in development of insulin resistance. Cell
Metab 15, 606–614.
41. Ross AB, Pere-Trepat E, Montoliu I et al. (2013) A
whole-grain-rich diet reduces urinary excretion of markers
of protein catabolism and gut microbiota metabolism in
healthy men after one week. J Nutr 143, 766–773.
42. McKeown NM, Troy LM, Jacques PF et al. (2010) Whole-
and refined-grain intakes are differentially associated with
abdominal visceral and subcutaneous adiposity in healthy
adults: the Framingham Heart Study. Am J Clin Nutr 92,
1165–1171.
43. Katcher HI, Legro RS, Kunselman AR et al. (2008) The
effects of a whole grain-enriched hypocaloric diet on car-
diovascular disease risk factors in men and women with
metabolic syndrome. Am J Clin Nutr 87, 79–90.
44. Kristensen M, Toubro S, Jensen MG et al. (2012) Whole
grain compared to refined wheat decreases the percentage
body fat following a 12-week energy restricted dietary
intervention in postmenopausal women. J Nutr 142,
710–716.
45. Ostler JE, Maurya SK, Dials J et al. (2014) Effects of insu-
lin resistance on skeletal muscle growth and exercise ca-
pacity in type 2 diabetic mouse models. Am J Physiol
Endocrinol Metab 306, E592–605.
46. Priebe MG, Wang H, Weening D et al. (2010) Factors re-
lated to colonic fermentation of nondigestible carbohy-
drates of a previous evening meal increase tissue glucose
uptake and moderate glucose-associated inflammation.
Am J Clin Nutr 91, 90–97.
47. Wurtz P, Makinen VP, Soininen P et al. (2012) Metabolic
signatures of insulin resistance in 7,098 young adults.
Diabetes 61, 1372–1380.
48. Wurtz P, Soininen P, Kangas AJ et al. (2013)
Branched-chain and aromatic amino acids are predictors
of insulin resistance in young adults. Diab Care 36,
648–655.
49. Walford GA, Davis J, Warner AS et al. (2013) Branched
chain and aromatic amino acids change acutely following
two medical therapies for type 2 diabetes mellitus.
Metabolism 62, 1772–1778.
50. Wang Z, Klipfell E, Bennett BJ et al. (2011) Gut flora
metabolism of phosphatidylcholine promotes cardiovascu-
lar disease. Nature 472, 57–63.
51. Ridaura VK, Faith JJ, Rey FE et al. (2013) Gut microbiota
from twins discordant for obesity modulate metabolism in
mice. Science 341, 1241214.
52. Beckmann M, Lloyd AJ, Haldar S et al. (2013)
Hydroxylated phenylacetamides derived from bioactive
benzoxazinoids are bioavailable in humans after habitual
consumption of whole grain sourdough rye bread. Mol
Nutr Food Res 57, 1859–1873.
53. Bondia-Pons I, Barri T, Hanhineva K et al. (2013)
UPLC-QTOF/MS metabolic profiling unveils urinary
changes in humans after a whole grain rye versus refined
wheat bread intervention. Mol Nutr Food Res 57, 412–422.
54. Hanhineva K, Keski-Rahkonen P, Lappi J et al. (2014)
The postprandial plasma rye fingerprint includes
benzoxazinoid-derived phenylacetamide sulfates. J Nutr
144, 1016–1022.
55. Primrose S, Draper J, Elsom R et al. (2011) Workshop re-
port: metabolomics and human nutrition. Br J Nutr 105,
1277–1283.
56. Hopton RP, Turner E, Burley VJ et al. (2010) Urine metab-
olite analysis as a function of deoxynivalenol exposure: an
NMR-based metabolomics investigation. Food addit
Contam A 27, 255–261.
Whole grains, metabolomics and health 327
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0029665114001542
Downloaded from https://www.cambridge.org/core. Chalmers Tekniska Högskola, on 30 Jul 2021 at 08:23:26, subject to the Cambridge Core terms of use, available at
